JAK3 activators are compounds designed to stimulate the activity or enhance the expression of Janus kinase 3 (JAK3). JAK3 is a member of the Janus kinase family, which consists of tyrosine kinases involved in initiating intracellular signaling cascades in response to extracellular cytokine stimulation. These kinases play essential roles in various cellular processes, including cell proliferation, differentiation, migration, and apoptosis. Specifically, JAK3 is associated with the signaling of certain cytokines that bind to the common gamma chain (γc) of cytokine receptors, such as interleukin-2 (IL-2), interleukin-4 (IL-4), interleukin-7 (IL-7), interleukin-9 (IL-9), interleukin-15 (IL-15), and interleukin-21 (IL-21).
The central role of JAK3 in mediating the signaling of these cytokines emphasizes its importance in modulating immune responses. Activation of JAK3 leads to the phosphorylation of signal transducers and activators of transcription (STATs), which subsequently dimerize and translocate to the nucleus, modulating the expression of target genes. JAK3 activators, by enhancing the kinase's activity or expression, can potentiate these signaling events, influencing a broad spectrum of cellular responses linked to the immune system. A deep understanding of JAK3 activation mechanisms is crucial in dissecting the complex interplay of intracellular signaling pathways that regulate immune functions. Investigating the realm of JAK3 activators sheds light on its pivotal role in orchestrating immune responses, emphasizing its central position in the cascade of events that define cellular reactions to external cytokine stimuli. This exploration underscores the delicate balance inherent in cellular signaling and the intricate network of interactions that ensure appropriate cellular responses to environmental cues.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Although primarily a tyrosine kinase inhibitor, its broad effects might impact JAK3 expression in certain contexts. | ||||||
Ruxolitinib | 941678-49-5 | sc-364729 sc-364729A sc-364729A-CW | 5 mg 25 mg 25 mg | $251.00 $500.00 $547.00 | 16 | |
Directly inhibits JAK1 and JAK2 but might indirectly influence JAK3 expression through feedback mechanisms. | ||||||
Stat3 Inhibitor VI, S3I-201 | 501919-59-1 | sc-204304 | 10 mg | $151.00 | 104 | |
By inhibiting STAT3, it can modulate JAK-STAT signaling potentially influencing JAK3 expression. | ||||||
Stat3 inhibitor V, stattic | 19983-44-9 | sc-202818 sc-202818A sc-202818B sc-202818C sc-202818D sc-202818E sc-202818F | 25 mg 100 mg 250 mg 500 mg 1 g 2.5 g 5 g | $130.00 $196.00 $274.00 $512.00 $731.00 $1408.00 $2091.00 | 114 | |
Inhibits STAT3 activation and dimerization, potentially impacting JAK3 expression through feedback. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Immunosuppressive drug that might have indirect effects on JAK3 expression. | ||||||
Piceatannol | 10083-24-6 | sc-200610 sc-200610A sc-200610B | 1 mg 5 mg 25 mg | $51.00 $71.00 $199.00 | 11 | |
Inhibits both Syk and JAK1, potentially influencing JAK3 expression. | ||||||
Niclosamide | 50-65-7 | sc-250564 sc-250564A sc-250564B sc-250564C sc-250564D sc-250564E | 100 mg 1 g 10 g 100 g 1 kg 5 kg | $38.00 $79.00 $188.00 $520.00 $1248.00 $5930.00 | 8 | |
Known to inhibit STAT3 signaling, which might indirectly influence JAK3 expression. | ||||||